How I Built This with Guy Raz HIBT Lab! Immunai: Noam Solomon
9 snips
Dec 22, 2022 Noam Solomon, Co-founder and CEO of Immunai, is revolutionizing drug development by using AI to map the human immune system. He discusses the staggering costs and inefficiencies of drug discovery while sharing how Immunai's innovative approach could change the landscape of personalized therapies for diseases like cancer. Noam emphasizes the importance of a culture that embraces uncertainty, which drives their scientific innovation. He also highlights the collaboration between data science and biology, aiming to create tailored treatment solutions that could improve patient outcomes.
AI Snips
Chapters
Transcript
Episode notes
Grandfather's Cancer
- Noam Solomon's co-founder shared a story about his grandfather's cancer treatment.
- His grandfather stopped immunotherapy due to side effects, eventually leading to his passing.
Importance of the Immune System
- Immunotherapies target the complex immune system, crucial for overall health and disease response.
- A key question is how to predict patient responses and personalize treatments.
Mapping the Immune System
- Mapping the immune system involves understanding individual cells and their interactions.
- Immunai uses single-cell technology to analyze vast amounts of data from patient samples.